Bolliger, D., Maurer, M. and Tanaka, K.A. (2020) Toward Optimal Anticoagulation Monitoring during Cardiopulmonary Bypass: It Is Still a Tough “ACT”. Journal of Cardiothoracic and Vascular Anesthesia, 34, 2928-2930.
https://doi.org/10.1053/j.jvca.2020.07.024

has been cited by the following article:

• TITLE: Abnormal ACT in a Patient with Prekallikrein Deficiency Undergoing Cardiopulmonary Bypass

  AUTHORS: Maria R. Fuertes, Naila Ahmad, Orlando Perez-Franco, Andrew Oster, Marion Svendrowski, Pin Yue

  KEYWORDS: Prekallikrein Deficiency, Fletcher Factor Deficiency, Cardiopulmonary Bypass, Congenital Cardiac Malformation

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.14 No.5, May 24, 2024

  ABSTRACT: Prekallikrein deficiency is a disorder that often remains undiagnosed. Prekallikrein activates factor XII, which initiates the intrinsic coagulation pathway. Prekallikrein deficiency results in prolonged Partial Thromboplastin Time and Activated Clotting Time in absence of anticoagulants or active bleeding. This case report describes the anesthesia management of a patient with Prekallikrein deficiency who underwent cardiac surgery with Cardiopulmonary Bypass for correction of a congenital cardiac malformation. We highlight the importance of understanding the different tests available for the diagnosis of coagulation factors deficiency during administration of heparin in the setting of cardiovascular procedures under general anesthesia.